Kyowa Hakko Kirin Expands KW-0761 To Relapsed T/NK Cell Lymphoma
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin has expanded clinical trials for KW-0761 for patients with adult T-cell lymphoma to include patients with relapsed and progressive T/NK cell lymphoma